Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Pharmaceutical Market (Trillion RUB), 2012-2017
Figure 4-2: Pharmaceutical Market Breakup by Segment (%), 2012-2017
Figure 4-3: Share of Branded and Generics in Pharmaceutical Market (2012)
Figure 4-4: Commercial Drugs Market (Trillion RUB), 2012-2017
Figure 4-5: Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Value (2011 & 2012)
Figure 4-6: State Segment Drugs Market (Billion RUB), 2012-2017
Figure 4-7: Disbursement under DLO Program (Billion RUB), 2011-2013
Figure 4-8: Share of Imported & Domestic Drugs under DLO Program by Sales Value (2011-2013)
Figure 4-9: Share of Imported & Domestic Drugs under Hospital Segment by Sales Value (2011-2013)
Figure 4-10: Parapharmaceutical Market (Billion RUB), 2012-2017
Figure 4-11: Nutritional Supplements Market (Billion RUB), 2011-2013
Figure 4-12: Share of Imported & Domestic Nutritional Supplements by Sales Value (2012)
Figure 5-1: Number of Clinical Trials Approved (2010-2012)
Figure 5-2: Clinical Trials by Therapeutic Area (%), 2012
Figure 5-3: Clinical Trials by Sponsor Country (%), 2012
Figure 6-1: Share of Pharmaceuticals' Sales by Price Bracket (2011 & 2012)
Figure 6-2: Gross National Income per Capita (‘000 US$), 2009-2012
Figure 6-3: Global - Distribution of Counterfeit Medicines (%), 2012

List of Tables:

Table 4-1: Commercial Drugs Sales Structure of ATC Groups (2012)
Table 4-2: Leading Companies in Commercial Drugs Market by Sales (Million RUB), 2012
Table 4-3: Leading Drugs in Commercial Drugs Market by Sales (Million RUB), 2012
Table 4-4: Drugs Sales Structure of ATC Groups under DLO Program (2012)
Table 4-5: Leading Companies under DLO Program by Sales (Million RUB), 2012
Table 4-6: Leading Drugs under DLO Program by Sales (Million RUB), 2012
Table 4-7: Drugs Sales Structure of ATC Groups under Hospital Segment (2012)
Table 4-8: Leading Companies under Hospital Segment by Sales (Million RUB), 2012
Table 4-9: Leading Drugs under Hospital Segment by Sales (Million RUB), 2012
Table 4-10: Leading Companies under Nutritional Supplement Segment by Sales (Million RUB), 2012
Table 4-11: Leading Distributors in Pharmaceutical Market by Sales (Million RUB), 2012
Table 8-1: Sanofi-Aventis - Key Financials (Million €), 2010-2012
Table 8-2: Sanofi-Aventis - Strengths & Weaknesses
Table 8-3: Novartis - Key Financials (Million US$), 2010-2012
Table 8-4: Novartis - Strengths & Weaknesses
Table 8-5: Pharmstandard - Strengths & Weaknesses